To include your compound in the COVID-19 Resource Center, submit it here.

Accelmed’s $100M fund targets early stage digital health plays

Israeli firm’s fund will seek out digital health companies it sees as takeout targets

Israeli fund group Accelmed has launched a $100 million fund to invest in health-tech companies it views as attractive takeover targets.

Accelmed Ventures II will focus on prerevenue med-tech and digital health companies in Israel and elsewhere. The fund will seek to make

Read the full 425 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers